About
Dr. Eric Leire is a biotech executive and physician best known as founder and CEO of Genflow Biosciences, a longevity-focused gene therapy company listed in London. Public bios also describe him as chairman of Immunethep and an independent or non-executive director at several biotech companies including OSE Immunotherapeutics, BSIM Therapeutics, and Inhatarget. Earlier in his career he served as CEO of Enochian Biosciences and DanDrit Biotech and was previously a partner at Biofund Venture Capital and Medwell Capital.
Areas of interest
longevitybiotechgene therapyhealthy agingoncologyanti-infectivesCNS therapeuticscell therapypharmaceutical commercializationventure capital